SECsense Logo

Cingulate Inc. 8-K Filing: Key Financial Insights & Stock Info as of Jan 7, 2025

$CING
Form 8-K
Filed on: 2025-01-07
Source
Cingulate Inc. 8-K Filing: Key Financial Insights & Stock Info as of Jan 7, 2025

Based on the provided XML section of the financial report, here are the key insights and information extracted:

  1. Entity Information:
  • Company Name: Cingulate Inc.
  • CIK (Central Index Key): 0001862150
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-40874
  • EIN (Employer Identification Number): 86-3825535
  • Address: 1901 W. 47th Place, Kansas City, KS 66205
  • Contact Number: (913) 942-2300
  1. Report Type:
  • Filing Type: 8-K (Report of unscheduled material events or corporate changes)
  • Filing Date: January 7, 2025
  1. Common Stock Information:
  • Par Value: $0.0001 per share
  • Ticker Symbol: CING (listed on NASDAQ)
  1. Warrants Information:
  • Warrants: Exercisable for one share of common stock
  • Warrant Ticker Symbol: CINGW (listed on NASDAQ)
  1. Financial Metrics:
  • Reporting Date: January 7, 2025
  • The report contains measures in USD and shares, indicating a financial metric presentation likely related to stock issuance or similar transactions.
  1. Periods:
  • The context indicates that all information is for a specific day (January 7, 2025), implying a snapshot of financial data or disclosures as of that date.

Insights:

  • The filing is a formal communication detailing significant corporate information, possibly related to securities (common stock and warrants).
  • The low par value of the common stock suggests a structure that may be typical for startup companies or those in early stages of financing.
  • The existence of tradable warrants indicates potential for raising additional capital or incentivizing investment, reflecting on the company's strategy for funding or expansion.

Summary:

This section of the financial report primarily outlines Cingulate Inc.'s stock and warrant information, along with essential corporate details, indicating an active engagement in capital markets as of early 2025. The filing may contain important implications for investors and stakeholders regarding the company's financial health and strategic direction.